Last updated: 11/04/2018 11:36:39
Bipolar Study in Adults at Least 18 Years of Age
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Lamictal for use in treatment of Bipolar Disorder In Adults. A Practical Clinical Assessment of Tolerability and Clinical Effectiveness.
Trial description: Bipolar study of tolerability, clinical response and patient satisfaction
Primary purpose:
Treatment
Trial design:
Single Group Assignment
Masking:
None (Open Label)
Allocation:
Non-randomized
Primary outcomes:
The primary endpoint will be the rate of rash during 12 weeks.
Timeframe: 12 Weeks
Secondary outcomes:
Change from baseline in Week 5 and Week 12 Clinical Global Impression-Bipolar version (CGI-BP) Severityand Improvement scores.
Timeframe: 12 Weeks
Interventions:
Enrollment:
1200
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Not applicable
- Diagnosis of bipolar I disorder.
- Must be on a stable regimen of psychiatric medication for at least 2 months prior to study.
- Patients with a clinically significant psychiatric or physiologic comorbidity including significant substance abuse, depression or mania which is of an unstable of progressive nature that could interfere in participation of this study.
Inclusion and exclusion criteria
Inclusion criteria:
- Diagnosis of bipolar I disorder.
- Must be on a stable regimen of psychiatric medication for at least 2 months prior to study.
- If female, must not be pregnant, or must be incapable of conceiving or be taking steps to prevent conception.
Exclusion criteria:
- Patients with a clinically significant psychiatric or physiologic comorbidity including significant substance abuse, depression or mania which is of an unstable of progressive nature that could interfere in participation of this study.
- Presence of untreated thyroid disease.
- Patient is actively suicidal or homicidal.
- Patient has history of severe hepatic or renal insufficiency.
- Patient is currently participating in another clinical trial.
Trial location(s)
Location
GSK Investigational Site
La Mesa, California, United States, 91941
Status
Study Complete
Location
GSK Investigational Site
Sacramento, California, United States, 95825
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Cerritos, California, United States, 90703
Status
Terminated/Withdrawn
Location
GSK Investigational Site
San Diego, California, United States, 92123
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Flowood, Mississippi, United States, 39232
Status
Study Complete
Location
GSK Investigational Site
Birmingham, Alabama, United States, 35234
Status
Study Complete
Location
GSK Investigational Site
Richmond, Virginia, United States, 23230
Status
Study Complete
Location
GSK Investigational Site
Libertyville, Illinois, United States, 60048
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Natrona Heights, Pennsylvania, United States, 15065
Status
Study Complete
Location
GSK Investigational Site
Raleigh, North Carolina, United States, 27605
Status
Study Complete
Location
GSK Investigational Site
Palm Beach Gardens, Florida, United States, 33410
Status
Study Complete
Location
GSK Investigational Site
Milwaukee, Wisconsin, United States, 53226
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Weirton, West Virginia, United States, 26062
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Winter Park, Florida, United States, 32789
Status
Study Complete
Location
GSK Investigational Site
Bradenton, Florida, United States, 34209
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Oklahoma City, Oklahoma, United States, 73118
Status
Study Complete
Location
GSK Investigational Site
Bristol, Tennessee, United States, 37620
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Ocala, Florida, United States, 34471
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Phoenix, Arizona, United States, 85032
Status
Study Complete
Location
GSK Investigational Site
Charleston, South Carolina, United States, 29407
Status
Study Complete
Location
GSK Investigational Site
Bellingham, Washington, United States, 98225
Status
Study Complete
Location
GSK Investigational Site
Oakdale, Minnesota, United States, 55128
Status
Study Complete
Location
GSK Investigational Site
Wilton Manors, Florida, United States, 33311
Status
Study Complete
Location
GSK Investigational Site
Phoenix, Arizona, United States, 85018
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Bedford, Texas, United States, 76022
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Vernon Hills, Illinois, United States, 60061
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Fort Walton Beach, Florida, United States, 32548
Status
Study Complete
Location
GSK Investigational Site
Charleston, West Virginia, United States, 25309
Status
Study Complete
Location
GSK Investigational Site
Plantation, Florida, United States, 33324
Status
Study Complete
Location
GSK Investigational Site
Wethersfield, Connecticut, United States, 06109
Status
Study Complete
Location
GSK Investigational Site
Plymouth, Indiana, United States, 46563
Status
Study Complete
Location
GSK Investigational Site
Cary, North Carolina, United States, 27511
Status
Study Complete
Location
GSK Investigational Site
Media, Pennsylvania, United States, 19063
Status
Study Complete
Location
GSK Investigational Site
Port Jefferson, New York, United States, 11777
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Springfield, Missouri, United States, 65804
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Laurel, Maryland, United States, 20707
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Miami, Florida, United States, 33176
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Boca Raton, Florida, United States, 33433
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Renton, Washington, United States, 98055
Status
Study Complete
Location
GSK Investigational Site
Farmington Hills, Michigan, United States, 48334
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Wheaton, Illinois, United States, 60187
Status
Study Complete
Location
GSK Investigational Site
Oklahoma City, Oklahoma, United States, 73109
Status
Study Complete
Location
GSK Investigational Site
Winter Park, Florida, United States, 32792
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Poway, California, United States, 92064
Status
Terminated/Withdrawn
Location
GSK Investigational Site
West Palm Beach, Florida, United States, 33407
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Gaithersburg, Maryland, United States, 20877
Status
Study Complete
Location
GSK Investigational Site
Baltimore, Maryland, United States, 21239
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Birmingham, Alabama, United States, 35209
Status
Study Complete
Location
GSK Investigational Site
Long Branch, New Jersey, United States, 07740
Status
Study Complete
Location
GSK Investigational Site
Raleigh, North Carolina, United States, 27607
Status
Study Complete
Location
GSK Investigational Site
Tulsa, Oklahoma, United States, 74136
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Park Ridge, Illinois, United States, 60068
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Wilmington, North Carolina, United States, 28401
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Coral Springs, Florida, United States, 33065
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Leavenworth, Kansas, United States, 66048
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Reading, Pennsylvania, United States, 19610
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Valparaiso, Indiana, United States, 46383
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Lexington, Kentucky, United States, 40509
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Knoxville, Tennessee, United States, 37919
Status
Study Complete
Location
GSK Investigational Site
Oklahoma City, Oklahoma, United States, 73103
Status
Terminated/Withdrawn
Location
GSK Investigational Site
St. Louis, Missouri, United States, 63117
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Daytona Beach, Florida, United States, 32114
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Rochester Hills, Michigan, United States, 48307
Status
Study Complete
Location
GSK Investigational Site
Milwaukie, Oregon, United States, 97222
Status
Study Complete
Location
GSK Investigational Site
Burtonsville, Maryland, United States, 20866
Status
Study Complete
Location
GSK Investigational Site
Adrian, Michigan, United States, 49221
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Miami, Florida, United States, 32216
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Chandler, Arizona, United States, 85225
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Chicago, Illinois, United States, 60657
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Baton Rouge, Louisiana, United States, 70806
Status
Study Complete
Location
GSK Investigational Site
Fairfield, California, United States, 94533
Status
Terminated/Withdrawn
Location
GSK Investigational Site
San Diego, California, United States, 92114
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Stockbridge, Georgia, United States, 30281
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Fort Wayne, Indiana, United States, 46805
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Las Vegas, Nevada, United States, 89030
Status
Study Complete
Location
GSK Investigational Site
Salt Lake City, Utah, United States, 84102
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Huntsville, Alabama, United States, 35802
Status
Study Complete
Location
GSK Investigational Site
Greensboro, North Carolina, United States, 27408
Status
Study Complete
Location
GSK Investigational Site
Raleigh, North Carolina, United States, 27612
Status
Study Complete
Location
GSK Investigational Site
High Point, North Carolina, United States, 27262
Status
Study Complete
Location
GSK Investigational Site
Petaluma, California, United States, 94952
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Jacksonville Beach, Florida, United States, 32250
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Pensacola, Florida, United States, 32503
Status
Study Complete
Location
GSK Investigational Site
Williston, Vermont, United States, 04495
Status
Study Complete
Location
GSK Investigational Site
New Rochelle, New York, United States, 10801
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Houston, Texas, United States, 77007
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Clinton Township, Michigan, United States, 48036
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Fairview Heights, Illinois, United States, 62208
Status
Study Complete
Location
GSK Investigational Site
Henderson, Nevada, United States, 89074
Status
Study Complete
Location
GSK Investigational Site
Cordova, Tennessee, United States, 38016
Status
Study Complete
Location
GSK Investigational Site
Durham, North Carolina, United States, 27705
Status
Study Complete
Location
GSK Investigational Site
Humble, Texas, United States, 77339
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Atlanta, Georgia, United States, 30030
Status
Study Complete
Location
GSK Investigational Site
Shreveport, Louisiana, United States, 71101
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Humble, Texas, United States, 77338
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Duluth, Minnesota, United States, 55802
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Overland Park, Kansas, United States, 66211
Status
Study Complete
Location
GSK Investigational Site
Orlando, Florida, United States, 32803
Status
Study Complete
Location
GSK Investigational Site
Orland Park, Illinois, United States, 60462
Status
Study Complete
Location
GSK Investigational Site
Madison, Tennessee, United States, 37115
Status
Study Complete
Location
GSK Investigational Site
Cincinnati, Ohio, United States, 45206
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Nashville, Tennessee, United States, 37203
Status
Study Complete
Location
GSK Investigational Site
St. Petersburg, Florida, United States, 33702
Status
Study Complete
Location
GSK Investigational Site
Doyletown, Pennsylvania, United States, 18901
Status
Study Complete
Location
GSK Investigational Site
Billings, Montana, United States, 59101
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Princeton, New Jersey, United States, 08540
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Rockville, Maryland, United States, 20852
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Boulder, Colorado, United States, 80303
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Little Rock, Arkansas, United States, 72201
Status
Study Complete
Location
GSK Investigational Site
Amityville, New York, United States, 11701
Status
Study Complete
Location
GSK Investigational Site
Phoenix, Arizona, United States, 85044
Status
Study Complete
Location
GSK Investigational Site
Racine, Wisconsin, United States, 53403
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Christiansburg, Virginia, United States, 24073
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Forest City, North Carolina, United States, 28043
Status
Study Complete
Location
GSK Investigational Site
Charleston, West Virginia, United States, 25301
Status
Study Complete
Location
GSK Investigational Site
Atlanta, Georgia, United States, 30338
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Kingston, Pennsylvania, United States, 18704
Status
Study Complete
Location
GSK Investigational Site
Las Vegas, Nevada, United States, 89102
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Altamonte Springs, Florida, United States, 32714
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Virginia Beach, Virginia, United States, 23452
Status
Will Be Recruiting
Location
GSK Investigational Site
Lawrenceville, Georgia, United States, 30045
Status
Study Complete
Location
GSK Investigational Site
Schaumburg, Illinois, United States, 60194
Status
Study Complete
Location
GSK Investigational Site
Mishawaka, Indiana, United States, 46545
Status
Terminated/Withdrawn
Location
GSK Investigational Site
New York, New York, United States, 10023
Status
Terminated/Withdrawn
Location
GSK Investigational Site
McKeesport, Pennsylvania, United States, 15132
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Mansfield Center, Connecticut, United States, 06250
Status
Study Complete
Location
GSK Investigational Site
Joplin, Missouri, United States, 64804
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Lafayette, Indiana, United States, 47904
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Clearwater, Florida, United States, 33764
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Evergreen Park, Illinois, United States, 60805
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Gulfport, Mississippi, United States, 39503
Status
Study Complete
Location
GSK Investigational Site
Tucson, Arizona, United States, 85719
Status
Terminated/Withdrawn
Location
GSK Investigational Site
St. Petersburg, Florida, United States, 33701
Status
Study Complete
Location
GSK Investigational Site
San Diego, California, United States, 92103
Status
Study Complete
Location
GSK Investigational Site
Glen Burnie, Maryland, United States, 21061
Status
Study Complete
Location
GSK Investigational Site
San Antonio, Texas, United States, 78229
Status
Study Complete
Location
GSK Investigational Site
Philadelphia, Pennsylvania, United States, 19139
Status
Study Complete
Location
GSK Investigational Site
Chapel Hill, North Carolina, United States, 27514
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Suffolk, Virginia, United States, 23434
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Chapel Hill, North Carolina, United States, 27517
Status
Study Complete
Location
GSK Investigational Site
Syracuse, Florida, United States, 13202
Status
Study Complete
Location
GSK Investigational Site
Granite City, Illinois, United States, 62040
Status
Study Complete
Location
GSK Investigational Site
Boise, Idaho, United States, 83704
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Danville, Virginia, United States, 24541
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Moncks Corner, South Carolina, United States, 29461
Status
Study Complete
Location
GSK Investigational Site
St. Charles, Missouri, United States, 63301
Status
Study Complete
Location
GSK Investigational Site
Fort Smith, Arkansas, United States, 72903
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Brandon, Florida, United States, 33511
Status
Study Complete
Location
GSK Investigational Site
Charlottesville, Virginia, United States, 22903
Status
Study Complete
Location
GSK Investigational Site
Sherman Oaks, California, United States, 91403
Status
Study Complete
Location
GSK Investigational Site
Towson, Maryland, United States, 21286
Status
Study Complete
Location
GSK Investigational Site
Kansas City, Missouri, United States, 64108
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Portland, Oregon, United States, 97210
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Annapolis, Maryland, United States, 21403
Status
Study Complete
Location
GSK Investigational Site
Goldsboro, North Carolina, United States, 27530
Status
Terminated/Withdrawn
Location
GSK Investigational Site
North Charleston, South Carolina, United States, 29406
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Dayton, Ohio, United States, 45459
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Lincoln, Nebraska, United States, 68502
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Knoxville, Tennessee, United States, 37922
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Lakeland, Florida, United States, 33803
Status
Terminated/Withdrawn
Location
GSK Investigational Site
East Moline, Illinois, United States, 61244
Status
Study Complete
Location
GSK Investigational Site
Casselberry, Florida, United States, 32730
Status
Study Complete
Location
GSK Investigational Site
Norfolk, Virginia, United States, 23505
Status
Study Complete
Location
GSK Investigational Site
Albany, New York, United States, 31701
Status
Study Complete
Location
GSK Investigational Site
San Jose, California, United States, 95123
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Brownstown Township, Michigan, United States, 48183
Status
Study Complete
Location
GSK Investigational Site
Oklahoma City, Oklahoma, United States, 73120
Status
Study Complete
Location
GSK Investigational Site
Falls Church, Virginia, United States, 22041
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Evansville, Indiana, United States, 47715
Status
Study Complete
Location
GSK Investigational Site
Omaha, Nebraska, United States, 68131
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Bay City, Michigan, United States, 48706
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Sarasota, Florida, United States, 34238
Status
Study Complete
Location
GSK Investigational Site
Los Angeles, California, United States, 90011
Status
Study Complete
Location
GSK Investigational Site
Cincinnati, Ohio, United States, 45243
Status
Study Complete
Location
GSK Investigational Site
Lake Charles, Louisiana, United States, 70601
Status
Study Complete
Location
GSK Investigational Site
Norwich, Connecticut, United States, 06360
Status
Study Complete
Location
GSK Investigational Site
Greenville, North Carolina, United States, 27858
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Arlington, Virginia, United States, 22205
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Pittsburgh, Pennsylvania, United States, 15243
Status
Study Complete
Location
GSK Investigational Site
Hopkinsville, Kentucky, United States, 42240
Status
Study Complete
Location
GSK Investigational Site
Warner Robins, Georgia, United States, 31093
Status
Study Complete
Location
GSK Investigational Site
Irving, Texas, United States, 75062
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Greenville, North Carolina, United States, 27834
Status
Study Complete
Location
GSK Investigational Site
Smithtown, New York, United States, 11787
Status
Study Complete
Location
GSK Investigational Site
El Centro, California, United States, 92243
Status
Study Complete
Location
GSK Investigational Site
Towson, Maryland, United States, 21204
Status
Study Complete
Location
GSK Investigational Site
Orange City, Florida, United States, 32763
Status
Study Complete
Location
GSK Investigational Site
Manchester, New Hampshire, United States, 03104
Status
Terminated/Withdrawn
Location
GSK Investigational Site
St. Louis, Missouri, United States, 63128
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Washington, District of Columbia, United States, 20011
Status
Study Complete
Location
GSK Investigational Site
Lisle, Illinois, United States, 60532
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Hamden, Connecticut, United States, 06514
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Colmar, Pennsylvania, United States, 18915
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Zephyrhills, Florida, United States, 33540
Status
Terminated/Withdrawn
Location
GSK Investigational Site
West Hollywood, California, United States, 90048
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Dubuque, Iowa, United States, 52001
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Farmingdale, New York, United States, 11735
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Wilmington, Delaware, United States, 19808
Status
Study Complete
Location
GSK Investigational Site
Tuscaloosa, Alabama, United States, 35404
Status
Study Complete
Location
GSK Investigational Site
Rockford, Illinois, United States, 61108
Status
Study Complete
Location
GSK Investigational Site
Youngstown, Ohio, United States, 44512
Status
Terminated/Withdrawn
Location
GSK Investigational Site
East Lansing, Michigan, United States, 48823
Status
Study Complete
Location
GSK Investigational Site
North Miami, Florida, United States, 33161
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Houston, Texas, United States, 77030
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Miami, Florida, United States, 33125
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Houma, Louisiana, United States, 70360
Status
Study Complete
Location
GSK Investigational Site
Fort Collins, Colorado, United States, 80525
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Mount Clemens, Michigan, United States, 48043
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Decatur, Georgia, United States, 30030
Status
Study Complete
Location
GSK Investigational Site
Ellicott City, Maryland, United States, 21043
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Cedar Rapids, Iowa, United States, 52402
Status
Study Complete
Location
GSK Investigational Site
Las Cruces, New Mexico, United States, 88011
Status
Study Complete
Location
GSK Investigational Site
Spokane, Washington, United States, 99204
Status
Study Complete
Location
GSK Investigational Site
Bourbonnais, Illinois, United States, 60914
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Raleigh, North Carolina, United States, 27609
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Phoenix, Arizona, United States, 85004
Status
Study Complete
Location
GSK Investigational Site
Shawnee Mission, Kansas, United States, 66214
Status
Study Complete
Location
GSK Investigational Site
Houston, Texas, United States, 77074
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Jacksonville, Florida, United States, 32257
Status
Study Complete
Location
GSK Investigational Site
Atlanta, Georgia, United States, 30309-7520
Status
Study Complete
Location
GSK Investigational Site
Birmingham, Alabama, United States, 35223
Status
Study Complete
Location
GSK Investigational Site
Charlotte, North Carolina, United States, 28211
Status
Study Complete
Location
GSK Investigational Site
Bakersfield, California, United States, 93309
Status
Study Complete
Location
GSK Investigational Site
Royal Oak, Michigan, United States, 48067
Status
Study Complete
Location
GSK Investigational Site
Santa Ana, California, United States, 92705
Status
Study Complete
Location
GSK Investigational Site
Joliet, Illinois, United States, 60435
Status
Study Complete
Location
GSK Investigational Site
Waukesha, Wisconsin, United States, 53188
Status
Study Complete
Location
GSK Investigational Site
Campbell, California, United States, 95008
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Murfreesboro, Tennessee, United States, 37129
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Tacoma, Washington, United States, 98499
Status
Study Complete
Location
GSK Investigational Site
Arlington, Texas, United States, 76012
Status
Study Complete
Location
GSK Investigational Site
Oakbrook Terrace, Illinois, United States, 60181
Status
Study Complete
Location
GSK Investigational Site
West Allis, Wisconsin, United States, 53227
Status
Study Complete
Location
GSK Investigational Site
Minneapolis, Minnesota, United States, 55454
Status
Study Complete
Location
GSK Investigational Site
Cuyahoga Falls, Ohio, United States, 44221
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Roswell, Georgia, United States, 30075
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Riverside, California, United States, 92506
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Bloomfield Hills, Michigan, United States, 48302
Status
Study Complete
Location
GSK Investigational Site
Santa Barbara, California, United States, 93102
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Batlimore, Maryland, United States, 21208
Status
Study Complete
Location
GSK Investigational Site
Nacogdoches, Texas, United States, 75965
Status
Study Complete
Location
GSK Investigational Site
Los Angeles, California, United States, 90089
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Sugar Land, Texas, United States, 77478
Status
Study Complete
Location
GSK Investigational Site
Mequion, Wisconsin, United States, 53092
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Rogers, Arizona, United States, 72756
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Kingsport, Tennessee, United States, 37664
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Wauwatosa, Wisconsin, United States, 53213
Status
Study Complete
Location
GSK Investigational Site
Johnson City, Tennessee, United States, 37601
Status
Study Complete
Location
GSK Investigational Site
Albuquerque, New Mexico, United States, 87108
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Boise, Idaho, United States, 83706
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Boynton Beach, Florida, United States, 33426
Status
Study Complete
Location
GSK Investigational Site
Laguna Hills, California, United States, 92653
Status
Study Complete
Location
GSK Investigational Site
Portsmouth, Virginia, United States, 23703
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Everett, Washington, United States, 98201
Status
Terminated/Withdrawn
Location
GSK Investigational Site
St. Louis, Missouri, United States, 63136-3675
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Albertville, Alabama, United States, 35950
Status
Study Complete
Location
GSK Investigational Site
Beverly Hills, California, United States, 90210
Status
Study Complete
Location
GSK Investigational Site
Newark, Delaware, United States, 19713
Status
Study Complete
Location
GSK Investigational Site
Burbank, California, United States, 91501
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Nashville, Tennessee, United States, 37204
Status
Study Complete
Location
GSK Investigational Site
Oceanside, California, United States, 92056
Status
Study Complete
Location
GSK Investigational Site
Fayetteville, North Carolina, United States, 28305
Status
Study Complete
Location
GSK Investigational Site
Davie, Florida, United States, 33024
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Cornelius, North Carolina, United States, 28031
Status
Study Complete
Location
GSK Investigational Site
Midlothian, Virginia, United States, 23112
Status
Study Complete
Location
GSK Investigational Site
Newport News, Virginia, United States, 23606
Status
Study Complete
Location
GSK Investigational Site
Boca Raton, Florida, United States, 33432
Status
Study Complete
Location
GSK Investigational Site
Torrance, California, United States, 90505
Status
Study Complete
Location
GSK Investigational Site
Benton Harbor, Michigan, United States, 49022
Status
Study Complete
Location
GSK Investigational Site
San Antonio, Texas, United States, 78232
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Jacksonville, Florida, United States, 32216
Status
Study Complete
Location
GSK Investigational Site
Gainesville, Florida, United States, 32607
Status
Study Complete
Location
GSK Investigational Site
Danville, Indiana, United States, 46122
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Boise, Idaho, United States, 83702
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Fairhope, Alabama, United States, 36532
Status
Study Complete
Location
GSK Investigational Site
North Little Rock, Arkansas, United States, 72113
Status
Study Complete
Location
GSK Investigational Site
Anniston, Alabama, United States, 36207
Status
Study Complete
Location
GSK Investigational Site
Latham, New York, United States, 12110
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Destin, Florida, United States, 32541
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Ashburn, Virginia, United States, 20147
Status
Study Complete
Study documents
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2004-05-08
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Participate in clinical trial
Additional information
Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.
Click hereAccess to clinical trial data by researchers
Visit website